CD8A and neoplasm: Activation of arginase-specific T cells by vaccination should cause T-cell infiltration at the tumor site, even in tumors with an “excluded” phenotype, without infiltrating T cells; arginase-expressing cells, such as tumor-associated macrophages (TAMs), have been described as excluding CD8(+) T cells from the tumor parenchyma [16].